Party Drug Ketamine (Special K) Likely To Become Anti-Depression Medicine

New Treatment Approach Improves Survival and Reduces Recurrence Risk for Patients With Muscle-Invasive Bladder Cancer

Study Reveals Structure of Brain Protein and Identifies Potential Drug Target for Epilepsy Research

Mount Sinai Study Detects Immune Changes Up to 10 Years Before Inflammatory Bowel Disease Is Diagnosed

Single-Cell Atlases of the Human Body May Not Fairly Represent Global Populations, Mount Sinai Study Finds

Mount Sinai Study Links Early-Life Exposure to PFAS ("Forever Chemicals") With Childhood Intestinal Inflammation

Researchers Identify Immune Cell That Builds Cancer-Fighting Hubs Inside Tumors

Loss of Radiation Therapy Clinics Could Widen Cancer Care Gaps Across the United States

Mount Sinai Receives $7.2 Million NIH Grant to Advance Precision Medicine for Peanut Allergy Treatment

Mount Sinai Researchers Discover Treatable Cause of Severe Anemia Associated With a Cancer Therapy

Study Finds Little to No Cortical Lewy Pathology in Living Parkinson’s Disease Patients Undergoing Deep Brain Stimulation

Equal Exposure, Unequal Impact: For First Time, Mount Sinai Researchers Show How Air Pollution Causes Greater Bone Loss in Some Women 50+